Published on : Sep 08, 2017
Fitbit has lately publicized a new partnership with Dexcom, a glucose monitoring device firm, for providing its customers with more than just fitness tracking. The wearable tech devices and activity trackers company has hoped to amplify its health monitoring capabilities with the help of this deal. People could be able to manage diabetes right on their wrists. The forthcoming Ionic smartwatch by Fitbit has been anticipated to receive Dexcom’s data, enabling the wearer to access glucose levels and also other stats such as heart rate and steps tracked by the device.
However, Ionic will not be able to continuously monitor glucose on its own–patients would be required to connect a Dexcom device to their Fitbit app.
Dexcom’s Not First Wearable Deal?
Following the announcement about the partnership between Fitbit and Dexcom, the former’s shares jumped 13.0% only to excite its shareholders. Since January when a 6.0% of its staff was laid off, the prices were higher for the company. It was also in the same month that it announced its plans to design a smartwatch.
Scheduled to show face in the coming month, Ionic will not be featuring the Dexcom functionality. The partners have been expected to aim for 2018 to roll out the connectivity, and yet there are more collaboration areas to be worked upon in the offing. With that said, Fitbit is not the only company to use Dexcom’s technology. Apple had announced the technology as an upcoming feature for its Watch in June at the Apple Worldwide Developers Conference (WWDC).